JCR Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	14,007	13,196	18,756	13,278	30,733
Short-Term Investments	-	-	-	-	244
Cash & Short-Term Investments	14,007	13,196	18,756	13,278	30,977
Cash Growth	6.15%	-29.64%	41.26%	-57.14%	17.96%
Receivables	14,162	12,236	14,934	11,137	15,585
Inventory	24,041	21,758	20,933	18,514	14,636
Other Current Assets	3,866	3,866	2,958	4,873	990
Total Current Assets	56,076	51,056	57,581	47,802	62,188
Property, Plant & Equipment	39,244	37,410	30,040	32,681	26,782
Long-Term Investments	8,852	10,442	9,819	9,443	2,769
Other Intangible Assets	2,596	2,960	3,496	3,652	2,960
Long-Term Deferred Tax Assets	2,466	2,985	1,288	1,357	2,433
Other Long-Term Assets	2	2	2	2	2
Total Assets	109,236	104,855	102,226	94,937	97,134
Accounts Payable	523	590	890	1,563	1,324
Accrued Expenses	1,261	1,216	1,130	1,088	1,004
Short-Term Debt	38,092	23,005	8,950	16,800	15,150
Current Portion of Long-Term Debt	3,600	3,050	-	500	-
Current Income Taxes Payable	3,403	3,097	4,402	2,836	11,104
Other Current Liabilities	1,256	13,030	14,763	12,975	13,472
Total Current Liabilities	48,135	43,988	30,135	35,762	42,054
Long-Term Debt	12,200	12,050	14,350	5,500	2,950
Pension & Post-Retirement Benefits	914	966	903	924	870
Other Long-Term Liabilities	631	418	364	339	173
Total Liabilities	61,880	57,422	45,752	42,525	46,047
Common Stock	9,061	9,061	9,061	9,061	9,061
Additional Paid-In Capital	10,378	10,392	10,384	10,384	10,994
Retained Earnings	31,226	31,191	37,278	34,273	33,241
Treasury Stock	-4,969	-5,066	-2,963	-2,978	-3,600
Comprehensive Income & Other	1,243	1,463	2,417	1,421	1,186
Total Common Equity	46,939	47,041	56,177	52,161	50,882
Minority Interest	417	392	297	251	205
Shareholders' Equity	47,356	47,433	56,474	52,412	51,087
Total Liabilities & Equity	109,236	104,855	102,226	94,937	97,134
Total Debt	53,892	38,105	23,300	22,800	18,100
Net Cash (Debt)	-39,885	-24,909	-4,544	-9,522	12,877
Net Cash Growth	-	-	-	-	57.81%
Net Cash Per Share	-327.06	-201.16	-36.24	-76.27	103.67
Filing Date Shares Outstanding	121.99	121.84	124.8	124.78	123.76
Total Common Shares Outstanding	121.99	121.84	124.8	124.78	123.76
Working Capital	7,941	7,068	27,446	12,040	20,134
Book Value Per Share	384.79	386.10	450.12	418.04	411.14
Tangible Book Value	44,343	44,081	52,681	48,509	47,922
Tangible Book Value Per Share	363.51	361.81	422.11	388.77	387.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.